4Front Ventures Corp.
company.status.inactiveCIK 1783875fmd_0THY3CXB41E0CXGFZ127MJ3WQ0Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2018 to Sep 30, 2024, 21 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Total revenues | 4 | 19 | 58 | 105 | 108 | 97 |
| Rental revenue | – | – | – | – | 9 | 9 |
| Cost of revenue | 2 | – | – | – | 56 | 52 |
| Property operating expenses | – | – | – | – | 14 | 18 |
| Gross profit | 1 | 8 | 37 | 49 | 51 | 46 |
| Realized investment gains (losses) | – | (1) | (1) | – | – | – |
| Selling, general and administrative | 12 | 34 | 44 | 48 | 56 | 63 |
| Total operating expenses | 14 | 188 | 69 | 64 | 66 | 67 |
| Compensation and benefits | – | 10 | 8 | 6 | 18 | 17 |
| Operating income | (12) | (180) | (33) | (14) | (15) | (21) |
| Interest expense | 2 | 6 | 16 | 14 | 13 | 14 |
| Interest and investment income | – | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | – | – | 1 | 0 | 4 | (17) |
| Income before taxes | (10) | (178) | (45) | (24) | (11) | (38) |
| Income tax expense | 0 | 1 | 15 | 14 | 10 | 7 |
| Net income from continuing operations | (10) | (179) | (60) | (38) | (21) | (45) |
| Net income | (9) | (182) | (47) | 38 | (47) | (92) |